CC
Casdin Capital Portfolio holdings
AUM
$1.1B
1-Year Return
24.98%
This Quarter Return
-6.37%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$1.28B
AUM Growth
-$235M
(-15%)
Cap. Flow
+$46.3M
Cap. Flow
% of AUM
3.62%
Top 10 Holdings %
Top 10 Hldgs %
65.3%
Holding
47
New
11
Increased
11
Reduced
7
Closed
3
Top Buys
| 1 |
Avidity Biosciences
RNA
|
$18.9M |
| 2 |
Pliant Therapeutics
PLRX
|
$17.9M |
| 3 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$16.5M |
| 4 |
NVTA
Invitae Corporation
NVTA
|
$14.7M |
| 5 |
4D Molecular Therapeutics
FDMT
|
$14M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$67.3M |
| 2 |
Relay Therapeutics
RLAY
|
$24.7M |
| 3 |
Exact Sciences
EXAS
|
$19.9M |
| 4 |
VERV
Verve Therapeutics
VERV
|
$17.2M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$9.73M |
Sector Composition
| 1 | Healthcare | 98.69% |
